1. Home
  2. GOGO vs KROS Comparison

GOGO vs KROS Comparison

Compare GOGO & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gogo Inc.

GOGO

Gogo Inc.

HOLD

Current Price

$4.18

Market Cap

566.2M

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.06

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOGO
KROS
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
566.2M
584.9M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
GOGO
KROS
Price
$4.18
$11.06
Analyst Decision
Hold
Buy
Analyst Count
2
7
Target Price
$15.00
$21.86
AVG Volume (30 Days)
1.3M
308.4K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.00
EPS
0.09
2.30
Revenue
$910,491,000.00
$243,864,000.00
Revenue This Year
$3.68
N/A
Revenue Next Year
$3.60
$2,751.79
P/E Ratio
$44.17
$4.81
Revenue Growth
104.74
N/A
52 Week Low
$3.85
$10.42
52 Week High
$16.82
$22.55

Technical Indicators

Market Signals
Indicator
GOGO
KROS
Relative Strength Index (RSI) 43.82 40.85
Support Level $4.17 $10.56
Resistance Level $5.07 $12.65
Average True Range (ATR) 0.23 0.35
MACD -0.06 0.02
Stochastic Oscillator 24.19 22.48

Price Performance

Historical Comparison
GOGO
KROS

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Gogo BA and Satcom Direct. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: